Claim your FREE trial subscription!
Prescription Medicines:
Espicom
Newsletter 46 issues per annum
Monitoring business developments in world anticancer drug markets is becoming more and more vital as cancer, in all its guises, remains one of the most resistant conditions. Cancer Drug News (CDN) can help you stay in touch with the companies, products, alliances and research that are shaping the global cancer market.
|
CDN saves you the time and effort of having to track the necessary information to keep up-to-date with this world market. Incorporating primary resource material, augmented with data from Espicom's unique intelligence base, CDN provides a compelling, easy-to-read route to complete market knowledge. |
|
Regular sections in CDN include: |
|
Breast Cancer · Haematological Cancer · Gastrointestinal Cancer · Lung Cancer · Gynaecological Cancer · Genitourinary Cancer · Brain Cancer · Head and Neck Cancer · Melanoma/Sarcoma · Therapies for Cancer-Related Complications · R&D highlights from International Conferences |
|
CDN is published weekly and is available by email on the day of publication. |
For full details, please email jenniferc@cmsinfo.com
CMS, P&A House, Alma Road, Chesham, Bucks. HP5 3HB, UK
Tel: +44 (0)1494 771734
Fax: +44 (0)1494 778994
e-mail: Jennifer Cowlard
copyright © 2008 all rights reserved
For more information about us, visit CMSinfo.
